AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11927473 — intervention group
Group type: COMPARATOR
Intervention: Propofol anesthesia with rocuronium (0.5 mg/kg at induction, followed by 0.3 mg/kg one hour later)
Number of subjects: 10
Study 11927473 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane anesthesia with rocuronium (0.5 mg/kg at induction, followed by 0.3 mg/kg one hour later)
Number of subjects: 10
Study 11927473 — intervention group
Group type: COMPARATOR
Intervention: Propofol anesthesia
Number of subjects: 10
Study 11927473 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane anesthesia
Number of subjects: 10
Study 11372092 — intervention group
Group type: EXPERIMENTAL
Intervention: Education group; received education materials about sealants.
Number of subjects: 312
Study 11372092 — intervention group
Group type: COMPARATOR
Intervention: No Education group; received no education materials until after the education phase.
Number of subjects: 312
Study 7552316 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical stimulation of the right index finger (task somatosensory evoked fields, task SEF's)
Number of subjects: 5
Study 7552316 — intervention group
Group type: EXPERIMENTAL
Intervention: Voluntary movement of the right index finger (movement-related fields, MRFs)
Number of subjects: 5
Study 7552316 — intervention group
Group type: COMPARATOR
Intervention: Control SEF's recorded at the beginning of the experiment
Number of subjects: 5
Study 2355105 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25 mg triazolam
Number of subjects: 30
Study 2355105 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg triazolam
Number of subjects: 30
Study 2355105 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 369395 — intervention group
Group type: EXPERIMENTAL
Intervention: Injectable haloperidol (initial doses ranging from 1 to 30 mg, maximum total daily dosage of 100 mg)
Number of subjects: 650
Study 31419583 — intervention group
Group type: EXPERIMENTAL
Intervention: 36 amino acid peptide
Number of subjects: 0
Study 31419583 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized peptide
Number of subjects: 0
Study 31419583 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study 28972191 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily acute intermittent hypoxia (AIH) + hand opening practice
Number of subjects: 6
Study 26513698 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow breathing training (SBT) using the RESPeRATE device, 10-12 weeks duration, 2 sessions of 15 minutes daily at 6 breaths/min
Number of subjects: 40
Study 26513698 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 40
Study 26513698 — intervention group
Group type: EXPERIMENTAL
Intervention: SBT
Number of subjects: 40
Study 26513698 — intervention group
Group type: COMPARATOR
Intervention: Usual care followed by SBT
Number of subjects: 40
Study 24410903 — intervention group
Group type: EXPERIMENTAL
Intervention: Walnut meal
Number of subjects: 16
Study 24410903 — intervention group
Group type: COMPARATOR
Intervention: Refined control meal
Number of subjects: 16
Study 22930087 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitomycin C application to the tympanic membrane before myringotomy
Number of subjects: 40
Study 22930087 — intervention group
Group type: COMPARATOR
Intervention: Normal saline application to the tympanic membrane before myringotomy (Control)
Number of subjects: 40
Study 19672601 — intervention group
Group type: EXPERIMENTAL
Intervention: Balneotherapy/Hydrotherapy
Number of subjects: 25
Study 19672601 — intervention group
Group type: EXPERIMENTAL
Intervention: Homeopathy
Number of subjects: 25
Study 19672601 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild Infrared Hyperthermia
Number of subjects: 25
Study 19672601 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness Meditation
Number of subjects: 25
Study 19672601 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 25
Study 19672601 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesendieck System
Number of subjects: 25
Study 19672601 — intervention group
Group type: EXPERIMENTAL
Intervention: Connective Tissue Massage
Number of subjects: 25
Study 19672601 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteopathy
Number of subjects: 25
Study 19672601 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnet Therapy
Number of subjects: 25
Study 19672601 — intervention group
Group type: COMPARATOR
Intervention: Qi Gong
Number of subjects: 25
Study 19672601 — intervention group
Group type: COMPARATOR
Intervention: Biofeedback
Number of subjects: 25
Study 19672601 — intervention group
Group type: COMPARATOR
Intervention: Body Awareness Therapy
Number of subjects: 25
Study 18055949 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium treatment
Number of subjects: 0
Study 16876249 — intervention group
Group type: EXPERIMENTAL
Intervention: VEGF Trap 0.3 mg/kg
Number of subjects: 25
Study 16876249 — intervention group
Group type: EXPERIMENTAL
Intervention: VEGF Trap 1.0 mg/kg
Number of subjects: 25
Study 16876249 — intervention group
Group type: EXPERIMENTAL
Intervention: VEGF Trap 3.0 mg/kg
Number of subjects: 25
Study 16876249 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 12152639 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic transabdominal preperitoneal patch technique (TAPP)
Number of subjects: 1042
Study 12152639 — intervention group
Group type: COMPARATOR
Intervention: Shouldice technique
Number of subjects: 1042
Study 10200011 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate aerosol 88 microg twice daily
Number of subjects: 128
Study 10200011 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate aerosol 220 microg twice daily
Number of subjects: 128
Study 10200011 — intervention group
Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide aerosol 200 microg 4 times daily
Number of subjects: 128
Study 10200011 — intervention group
Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide aerosol 400 microg twice daily
Number of subjects: 128
Study 10200011 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone 10 mg once daily
Number of subjects: 128
Study 10200011 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study 7598932 — intervention group
Group type: EXPERIMENTAL
Intervention: 100% oxygen (O2) for 1 minute
Number of subjects: 40
Study 7598932 — intervention group
Group type: EXPERIMENTAL
Intervention: 100% oxygen (O2) for 2 minutes
Number of subjects: 40
Study 7598932 — intervention group
Group type: EXPERIMENTAL
Intervention: 100% oxygen (O2) for 3 minutes
Number of subjects: 40
Study 7598932 — intervention group
Group type: EXPERIMENTAL
Intervention: Succinylcholine 1.5 mg/kg (Group 4)
Number of subjects: 40
Study 1977869 — intervention group
Group type: EXPERIMENTAL
Intervention: High protein (2.5‐3.0 g/kg), high calorie (BEE x 1.2 x 1.6) diet
Number of subjects: 60
Study 1977869 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderately high protein (2.0‐2.5 g/kg), high calorie diet
Number of subjects: 60
Study 1977869 — intervention group
Group type: COMPARATOR
Intervention: Normal protein (1‐1.5 g/kg), normal calorie (30‐35 Kcal/kg) diet
Number of subjects: 60
Study 874673 — intervention group
Group type: EXPERIMENTAL
Intervention: Phototherapy (Group I)
Number of subjects: 2
Study 874673 — intervention group
Group type: EXPERIMENTAL
Intervention: Phototherapy (Group II)
Number of subjects: 2
Study 874673 — intervention group
Group type: COMPARATOR
Intervention: Control (Group I)
Number of subjects: 2
Study 874673 — intervention group
Group type: COMPARATOR
Intervention: Control (Group II)
Number of subjects: 2
Study 30844992 — intervention group
Group type: EXPERIMENTAL
Intervention: Hang cleans at 90% of 1 repetition maximum (1RM)
Number of subjects: 12
Study 30465635 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic training in mineral geothermal water (2 days/week, 30-40 minutes, 60%-75% of HRmax)
Number of subjects: 20
Study 30465635 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided)
Number of subjects: 20
Study 31083056 — intervention group
Group type: EXPERIMENTAL
Intervention: Blended collaborative care for depression and HFrEF
Number of subjects: 750
Study 31083056 — intervention group
Group type: COMPARATOR
Intervention: Enhanced usual care for HFrEF
Number of subjects: 750
Study 31083056 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC) for HFrEF
Number of subjects: 750
Study 27861238 — intervention group
Group type: COMPARATOR
Intervention: Low ICFI score (compared to high ICFI score)
Number of subjects: 2092
Study 27861238 — intervention group
Group type: COMPARATOR
Intervention: Low dietary diversity score (compared to high dietary diversity score)
Number of subjects: 2092
Study 27861238 — intervention group
Group type: COMPARATOR
Intervention: Low food consistency score
Number of subjects: 2092
Study 26074027 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous transluminal angioplasty (PTA)
Number of subjects: 14
Study 26074027 — intervention group
Group type: EXPERIMENTAL
Intervention: VIABAHN stent graft placement
Number of subjects: 14
Study 23523291 — intervention group
Group type: EXPERIMENTAL
Intervention: Best Clinical Judgment (BCJ) with PCA3
Number of subjects: 1024
Study 23523291 — intervention group
Group type: COMPARATOR
Intervention: Best Clinical Judgment (BCJ) alone
Number of subjects: 1024
Study 23523291 — intervention group
Group type: COMPARATOR
Intervention: PCA3 alone (cutoff score 20)
Number of subjects: 1024
Study 23523291 — intervention group
Group type: EXPERIMENTAL
Intervention: BCJ with PCA3
Number of subjects: 1024
Study 21762871 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil (4.6 g/day of long-chain ω-3 fatty acids)
Number of subjects: 200
Study 21762871 — intervention group
Group type: COMPARATOR
Intervention: Control oil
Number of subjects: 200
Study 19415308 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast-track (FT) protocols
Number of subjects: 1021
Study 19415308 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 1021
Study 16264050 — intervention group
Group type: EXPERIMENTAL
Intervention: Cotton dust exposure
Number of subjects: 447
Study 16264050 — intervention group
Group type: EXPERIMENTAL
Intervention: Cotton dust exposure cessation
Number of subjects: 447
Study 16264050 — intervention group
Group type: EXPERIMENTAL
Intervention: Persistent byssinotic symptoms
Number of subjects: 447
Study 16264050 — intervention group
Group type: EXPERIMENTAL
Intervention: Endotoxin exposure
Number of subjects: 447
Study 16264050 — intervention group
Group type: COMPARATOR
Intervention: Silk textile control
Number of subjects: 447
Study 10494875 — intervention group
Group type: EXPERIMENTAL
Intervention: Postmenarcheal girls
Number of subjects: 300
Study 10494875 — intervention group
Group type: COMPARATOR
Intervention: Pre- and postmenarcheal girls
Number of subjects: 300
Study 10494875 — intervention group
Group type: EXPERIMENTAL
Intervention: Postmenarcheal adolescents
Number of subjects: 300
Study 10494875 — intervention group
Group type: COMPARATOR
Intervention: Healthy girls and young women
Number of subjects: 300
Study 7500246 — intervention group
Group type: EXPERIMENTAL
Intervention: Titanium reinforced membranes positioned just apical to the cemento-enamel junction and the modified papilla preservation technique
Number of subjects: 45
Study 7500246 — intervention group
Group type: COMPARATOR
Intervention: Conventional expanded polytetrafluoroethylene (ePTFE) barrier membranes applied at the alveolar crest
Number of subjects: 45
Study 7500246 — intervention group
Group type: COMPARATOR
Intervention: Access flap procedure
Number of subjects: 45
Study 1773454 — intervention group
Group type: EXPERIMENTAL
Intervention: Ke Chuan Ping decoction (KCP)
Number of subjects: 62
Study 1773454 — intervention group
Group type: COMPARATOR
Intervention: Traditional prescription Qing Jin Hua Tan decoction (QJHT)
Number of subjects: 62
Study 6813483 — intervention group
Group type: EXPERIMENTAL
Intervention: Auranofin (AF)
Number of subjects: 103
Study 6813483 — intervention group
Group type: COMPARATOR
Intervention: Sodium aurothiomalate (GSTM)
Number of subjects: 103
Study 31846375 — intervention group
Group type: EXPERIMENTAL
Intervention: PACS-integrated peer review tool
Number of subjects: 38
Study 31846375 — intervention group
Group type: COMPARATOR
Intervention: Nonadopters group (control)
Number of subjects: 38
Study 30860197 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-stay protocol (ambulated and graded oral intake initiated from 6 h post-operation, urethral catheters discontinued at 12 h, discharged on the 3rd day post-op)
Number of subjects: 0
Study 30860197 — intervention group
Group type: COMPARATOR
Intervention: Traditional protocol (ambulated from 12 h, graded oral intake initiated at 24 h, urethral catheters removed at 24 h, discharged on the 5th day post-op)
Number of subjects: 0
Study 30498520 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 seconds of weight-bearing heel raises
Number of subjects: 48
Study 26908726 — intervention group
Group type: EXPERIMENTAL
Intervention: 2D (M0,6)
Number of subjects: 1447
Study 26908726 — intervention group
Group type: EXPERIMENTAL
Intervention: 2D (M0,12)
Number of subjects: 1447
Study 24248149 — intervention group
Group type: EXPERIMENTAL
Intervention: Inpatient rehabilitation programme (adapted physical activity within a cognitive behavioural framework)
Number of subjects: 60
Study 24248149 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control condition
Number of subjects: 60
Study 21781012 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole 1% and urea 40%
Number of subjects: 70
Study 21781012 — intervention group
Group type: COMPARATOR
Intervention: Fluconazole 1% alone
Number of subjects: 70
Study 19463080 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise program (eight classes of 40-45 minutes duration over eight weeks conducted by a physiotherapist)
Number of subjects: 72
Study 19463080 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise program
Number of subjects: 72
Study 19463080 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 72
Study 17565288 — intervention group
Group type: EXPERIMENTAL
Intervention: Care for Development (CFD) counseling materials provided to 50 families
Number of subjects: 100
Study 17565288 — intervention group
Group type: COMPARATOR
Intervention: Control group (50 families without CFD counseling)
Number of subjects: 100
Study 15031565 — intervention group
Group type: COMPARATOR
Intervention: Moderate asthma patients
Number of subjects: 133
Study 15031565 — intervention group
Group type: COMPARATOR
Intervention: Asthma patients (both mild and moderate)
Number of subjects: 133
Study 15031565 — intervention group
Group type: COMPARATOR
Intervention: Subjects with slightly elevated CRP levels (> or =1.8 mg/l)
Number of subjects: 133
Study 12083284 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured Play (SP)
Number of subjects: 8
Study 12083284 — intervention group
Group type: COMPARATOR
Intervention: Facilitated Play (FP)
Number of subjects: 8
Study 9690059 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient structured diabetes treatment and teaching programme (DTTP)
Number of subjects: 72
Study 9690059 — intervention group
Group type: COMPARATOR
Intervention: Inpatient structured diabetes treatment and teaching programme (DTTP)
Number of subjects: 72
Study 7654895 — intervention group
Group type: EXPERIMENTAL
Intervention: Pantoprazole 40 mg
Number of subjects: 286
Study 7654895 — intervention group
Group type: COMPARATOR
Intervention: Omeprazole 20 mg
Number of subjects: 286
Study 29091516 — intervention group
Group type: EXPERIMENTAL
Intervention: Bosutinib 400 mg once daily (n = 268)
Number of subjects: 536
Study 29091516 — intervention group
Group type: COMPARATOR
Intervention: Imatinib (n = 268)
Number of subjects: 536
Study 28865495 — intervention group
Group type: EXPERIMENTAL
Intervention: left prefrontal rTMS treatment
Number of subjects: 360
Study 28865495 — intervention group
Group type: COMPARATOR
Intervention: sham (control) rTMS treatment
Number of subjects: 360
Study 26634593 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT) at dosage of 2000 UI
Number of subjects: 61
Study 26634593 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT) at dosage of 4000 UI
Number of subjects: 61
Study 22998461 — intervention group
Group type: EXPERIMENTAL
Intervention: PRGF
Number of subjects: 28
Study 22998461 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 28
Study 21150855 — intervention group
Group type: EXPERIMENTAL
Intervention: Total intravenous anesthesia (TIVA) with propofol and remifentanil
Number of subjects: 50
Study 21150855 — intervention group
Group type: COMPARATOR
Intervention: Inhalational anesthesia (INHAL) with sevoflurane and fentanyl
Number of subjects: 50
Study 19563193 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture plus Chinese medicine (group ACUP+CM)
Number of subjects: 90
Study 19563193 — intervention group
Group type: COMPARATOR
Intervention: Control group (group CONT)
Number of subjects: 90
Study 19563193 — intervention group
Group type: COMPARATOR
Intervention: Chinese medicine group (group CM)
Number of subjects: 90
Study 18705976 — intervention group
Group type: EXPERIMENTAL
Intervention: B vitamins (folic acid 2 mg, B(6) 25 mg, B(12) 500 microg)
Number of subjects: 8000
Study 18705976 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8000
Study 18705976 — intervention group
Group type: EXPERIMENTAL
Intervention: B vitamins
Number of subjects: 8000
Study 15526253 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication management
Number of subjects: 61
Study 15526253 — intervention group
Group type: EXPERIMENTAL
Intervention: Family psychosocial interventions
Number of subjects: 61
Study 11567700 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 MU subcutaneously of recombinant interferon alpha‐2a three times a week for 3 years
Number of subjects: 424
Study 11567700 — intervention group
Group type: COMPARATOR
Intervention: Observation alone after surgery
Number of subjects: 424
Study 11567700 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery plus interferon alpha‐2a
Number of subjects: 424
Study 11567700 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 424
Study 9778073 — intervention group
Group type: EXPERIMENTAL
Intervention: Digitalis
Number of subjects: 80
Study 9778073 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 8152935 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenatal class intervention for clarifying support expectations
Number of subjects: 0
Study 8152935 — intervention group
Group type: EXPERIMENTAL
Intervention: Confirmation of expectations for mutual support after childbirth
Number of subjects: 0
Study 8152935 — intervention group
Group type: EXPERIMENTAL
Intervention: Support received
Number of subjects: 0
Study 3136954 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg t-PA over 6 hours
Number of subjects: 36
Study 3136954 — intervention group
Group type: COMPARATOR
Intervention: 100 mg t-PA over 6 hours
Number of subjects: 36
Study 29954942 — intervention group
Group type: EXPERIMENTAL
Intervention: Western dietary pattern (high intake of high-fat dairy products, processed meat, refined grains, sweets, caloric drinks, and convenience food)
Number of subjects: 369
Study 29954942 — intervention group
Group type: COMPARATOR
Intervention: Mediterranean dietary pattern
Number of subjects: 369
Study 29954942 — intervention group
Group type: COMPARATOR
Intervention: Prudent dietary pattern
Number of subjects: 369
Study 29061128 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week multi-level intervention
Number of subjects: 1000
Study 24283931 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept 50 mg once weekly or twice weekly for 12 weeks
Number of subjects: 0
Study 24283931 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept 50 mg once weekly for 24 weeks
Number of subjects: 0
Study 24283931 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept treatment
Number of subjects: 0
Study 23634911 — intervention group
Group type: EXPERIMENTAL
Intervention: prouk-PCI
Number of subjects: 197
Study 23634911 — intervention group
Group type: COMPARATOR
Intervention: PCI
Number of subjects: 197
Study 21374690 — intervention group
Group type: EXPERIMENTAL
Intervention: Previous HBV infection (anti-HBc positive)
Number of subjects: 273
Study 21374690 — intervention group
Group type: EXPERIMENTAL
Intervention: Previous HBV infection (anti-HBc alone)
Number of subjects: 273
Study 21374690 — intervention group
Group type: EXPERIMENTAL
Intervention: Occult HBV infection (HBV DNA in liver)
Number of subjects: 273
Study 21374690 — intervention group
Group type: COMPARATOR
Intervention: HBV DNA in serum
Number of subjects: 273
Study 18171701 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic L-T3 infusion (initial dose: 20 microg/m(2) body surface.d)
Number of subjects: 20
Study 18171701 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 20
Study 16829189 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug treatment directed by plasma NTproBNP
Number of subjects: 360
Study 16829189 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive standardised clinical assessment
Number of subjects: 360
Study 16829189 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 360
Study 14550448 — intervention group
Group type: EXPERIMENTAL
Intervention: 78 Gy radiotherapy
Number of subjects: 301
Study 14550448 — intervention group
Group type: COMPARATOR
Intervention: 70 Gy radiotherapy
Number of subjects: 301
Study 14550448 — intervention group
Group type: EXPERIMENTAL
Intervention: Both 70 Gy and 78 Gy radiotherapy
Number of subjects: 301
Study 10809983 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquiritin cream applied twice daily for 4 weeks
Number of subjects: 20
Study 10809983 — intervention group
Group type: COMPARATOR
Intervention: Vehicle cream applied twice daily for 4 weeks
Number of subjects: 20
Study 8793417 — intervention group
Group type: EXPERIMENTAL
Intervention: Partially hydrogenated fish oil (PHFO‐diet)
Number of subjects: 33
Study 8793417 — intervention group
Group type: EXPERIMENTAL
Intervention: Partially hydrogenated soybean oil (PHSO‐diet)
Number of subjects: 33
Study 8793417 — intervention group
Group type: EXPERIMENTAL
Intervention: Butterfat (butter‐diet)
Number of subjects: 33
Study 8793417 — intervention group
Group type: COMPARATOR
Intervention: All diets (PHFO, PHSO, butter)
Number of subjects: 33
Study 1290244 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral hydrolytic enzymes
Number of subjects: 19
Study 1290244 — intervention group
Group type: COMPARATOR
Intervention: Oral gold salts
Number of subjects: 19
Study 1290244 — intervention group
Group type: EXPERIMENTAL
Intervention: Both therapies
Number of subjects: 19